These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15255559)

  • 1. Levofloxacin: a suitable option for the infectious disease consultant.
    Viale P; Scudeller L; Cristini F
    J Chemother; 2004 Apr; 16 Suppl 2():22-4. PubMed ID: 15255559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical positioning of levofloxacin in the treatment of nosocomial pneumonia].
    Beloborodov VB
    Antibiot Khimioter; 2008; 53(9-10):12-20. PubMed ID: 19441645
    [No Abstract]   [Full Text] [Related]  

  • 3. [Present aspects and prospects of levofloxacin use in therapy of nosocomial pneumonia].
    Riabkova EL; Kozlov RS
    Antibiot Khimioter; 2008; 53(9-10):6-11. PubMed ID: 19441644
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: non-adherence to infectious diseases consultations: are surgeons to blame?
    Pulcini C
    J Antimicrob Chemother; 2006 Nov; 58(5):1095. PubMed ID: 16950821
    [No Abstract]   [Full Text] [Related]  

  • 5. Levofloxacin in the treatment of pneumonia in intensive care unit patients.
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sanchez M; Bermejo B;
    J Chemother; 2004 Dec; 16(6):549-56. PubMed ID: 15700846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic strategy in an infectious diseases unit].
    Dupon M
    Presse Med; 2000 Jan; 29(2):121-3. PubMed ID: 10682044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Levofloxacin in the treatment of nosocomial infection in critically ill patients].
    Alvarez Lerma F; Romero Luján JL; Morón Jiménez A; Ortiz López R; Borges Sá M; Grau Cerrato S; Gracia Arnillas MP;
    Rev Esp Quimioter; 2008 Jun; 21(2):83-92. PubMed ID: 18509767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
    Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
    Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
    Lanzafame A; Bonfiglio G; Santini L; Mattina R
    Chemotherapy; 2005 Mar; 51(1):44-50. PubMed ID: 15767745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do intensive care patients need an individualized dosing regimen for levofloxacin?
    Tayab ZR; Hochhaus G; Kaufmann S; Jäger D; Barth J
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):262-9. PubMed ID: 16800098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of recommendations by clinical microbiologists on antimicrobial treatment in the intensive care units of a Dublin teaching hospital.
    O'Neill E; Humphreys H; Smyth E
    Clin Infect Dis; 2005 Feb; 40(4):636-7. PubMed ID: 15712097
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
    Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
    Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
    Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
    Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment for Legionnaires' disease. Macrolides or quinolones?].
    Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A
    Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain.
    Biller P; Shank B; Lind L; Brennan M; Tkatch L; Killgore G; Thompson A; McDonald LC
    Infect Control Hosp Epidemiol; 2007 Feb; 28(2):198-201. PubMed ID: 17265402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
    Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present positioning of levofloxacin in chemotherapy of bacterial infections].
    Iakovlev VP
    Antibiot Khimioter; 2008; 53(9-10):3-5. PubMed ID: 19441643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of levofloxacin in the hospital].
    Castells X; Vallano A; Campany D; Rigau D; Arnau JM
    Rev Esp Quimioter; 2003 Jun; 16(2):221-6. PubMed ID: 12973461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience accumulated in hospital setting with levofloxacin, in monotherapy and in association therapy].
    Petrosillo N
    Infez Med; 2009 Dec; 17 Suppl 5():36-44. PubMed ID: 20424535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.